Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MAP4K1 antisense RNA 1 (MAP4K1-AS1) is a long noncoding natural antisense transcript located at the MAP4K1 genomic locus and transcribed from the DNA strand opposite to the protein-coding MAP4K1 gene. Antisense RNAs, including MAP4K1-AS1, regulate gene expression by mechanisms such as transcriptional interference, chromatin remodeling, and modulating transcription factor recruitment. While many antisense RNAs are increasingly recognized for their roles in epigenetic regulation and disease, there is currently little published data assigning a definitive functional role or disease link to MAP4K1-AS1 specifically. It is not categorized as a direct therapeutic target (such as a receptor, enzyme, or ion channel), but may emerge as a regulatory RNA relevant to future research in gene regulation and noncoding RNA biology.
Not applicable (no drugs known that act directly on MAP4K1-AS1); in general, antisense RNAs can affect gene expression through transcriptional interference, promoter competition, and chromatin remodeling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MAP4K1 antisense RNA 1 (MAP4K1-AS1).